- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Devyser Diagnostics AB (DVYSR)
Track the Devyser Diagnostics AB share price today and view real-time DVYSR share price data, including charts, technicals, and key financials. View the DVYSR premarket stock price ahead of the market session or assess the after hours quote. Explore DVYSR stock price movements, trading volume, and market activity across the ST exchange.
What Is the Devyser Diagnostics AB Stock Price Today?
The Devyser Diagnostics AB stock price today is 64.90.
What Is the Stock Symbol for Devyser Diagnostics AB?
The stock symbol for Devyser Diagnostics AB is ""DVYSR.""
What Stock Exchange Does Devyser Diagnostics AB Trade On?
Devyser Diagnostics AB is listed and trades on the Stockholm stock exchange.
Is Devyser Diagnostics AB a Good Stock to Buy?
Determining whether Devyser Diagnostics AB or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DVYSR quote. (ISIN: SE0016588867)
What Is the Devyser Diagnostics AB Stock Price Today?
The Devyser Diagnostics AB stock price today is 64.90.
What Is the Stock Symbol for Devyser Diagnostics AB?
The stock symbol for Devyser Diagnostics AB is ""DVYSR.""
What Stock Exchange Does Devyser Diagnostics AB Trade On?
Devyser Diagnostics AB is listed and trades on the Stockholm stock exchange.
Is Devyser Diagnostics AB a Good Stock to Buy?
Determining whether Devyser Diagnostics AB or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DVYSR quote. (ISIN: SE0016588867)
Stockholm
Currency in SEK
64.90
+3.40(+5.53%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
62.00
68.00
52 wk Range
48.50
124.00
Earnings results expected today
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
62.0068.00
52 wk Range
48.50124.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DVYSR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
96.17
Upside
+48.18%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 96.17
(+48.18% Upside)
Devyser Diagnostics AB Earnings Call Summary for Q3/2026
- Devyser Q3 revenue rose 5.8% to 59.7M SEK; EBIT surged to 7.1M SEK from 1.3M SEK YoY, marking sixth consecutive profitable quarter.
- Gross margin rebounded to 83% after Q2 inventory hit; operating cash flow swung to positive 22M SEK from negative 0.5M SEK prior year.
- Company expanded Accept transplant platform to heart and lung monitoring beyond kidney; signed first Illumina reagent rental deal in Italy.
- Largest distributor inventory normalization to pressure sales through 2026; management expects channel recovery beginning early 2027.
- Long-term 30% growth target contingent on pending MolDx decision (expected by year-end) and subsequent FDA approval for U.S. market entry.
Last Updated: 03/11/2026, 08:34 pm
Read Full TranscriptEarnings
Latest Release
20/07/2026
EPS / Forecast
0.10 / 0.68
Revenue / Forecast
60.2M / 77.9M
Compare DVYSR to Peers and Sector
Metrics to compare | DVYSR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDVYSRPeersSector | |
|---|---|---|---|---|
P/E Ratio | 67.4x | −1.1x | −0.2x | |
PEG Ratio | 0.51 | −0.02 | 0.00 | |
Price/Book | 2.7x | 2.8x | 2.6x | |
Price / LTM Sales | 4.1x | 8.6x | 2.8x | |
Upside (Analyst Target) | 51.0% | 12.7% | 65.5% | |
Fair Value Upside | Unlock | 3.1% | 8.9% | Unlock |
Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa. It offers kits and reagents, such as post-transplantation, thalassemia, fetal RHD screening NIPT, Cystic fibrosis cardiovascular diseases, male infertility, rapid aneuploidy analysis, accessories, hereditary cancer, and transfusion medicine products; and Amplicon Suite and Advyser for cloud-based software solutions for data analysis and the interpretation of test results. The company was incorporated in 2004 and is headquartered in Årsta, Sweden.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Devyser Diagnostics AB (DVYSR) Stock Price Today?
The Devyser Diagnostics AB stock price today is 64.90 SEK.
What Stock Exchange Does Devyser Diagnostics AB Trade On?
Devyser Diagnostics AB is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Devyser Diagnostics AB?
The stock symbol for Devyser Diagnostics AB is "DVYSR."
What Is the Devyser Diagnostics AB Market Cap?
As of today, Devyser Diagnostics AB market cap is 1.04B SEK.
What Is Devyser Diagnostics AB's Earnings Per Share (TTM)?
The Devyser Diagnostics AB EPS (TTM) is 0.92.
When Is the Next Devyser Diagnostics AB Earnings Date?
Devyser Diagnostics AB will release its next earnings report on 03/11/2026.
From a Technical Analysis Perspective, Is DVYSR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Devyser Diagnostics AB Stock Split?
Devyser Diagnostics AB has split 0 times.
How Many Employees Does Devyser Diagnostics AB Have?
Devyser Diagnostics AB has 110 employees.
What is the current trading status of Devyser Diagnostics AB (DVYSR)?
As of 03/11/2026, Devyser Diagnostics AB (DVYSR) is trading at a price of 64.90 SEK, with a previous close of 61.50 SEK. The stock has fluctuated within a day range of 62.00 SEK to 68.00 SEK, while its 52-week range spans from 48.50 SEK to 124.00 SEK.
What Is Devyser Diagnostics AB (DVYSR) Price Target According to Analysts?
The average 12-month price target for Devyser Diagnostics AB is 96.17 SEK, with a high estimate of 104.05274725 SEK and a low estimate of 88.28131868 SEK. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +48.18% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.